Transcriptomics

Dataset Information

3

Exon array analysis of the response to bevacizumab/erlotinib in advanced non-small cell lung cancer


ABSTRACT: In the current study, we used exon arrays and clinical samples from a previous trial (SAKK 19/05) to investigate the expression variations at the exon-level of 3 genes potentially playing a key role in modulating treatment response (EGFR, KRAS, VEGFA). Exon-level biomarkers for the response to targeted therapy bevacizumab/erlotinib were identified in patients with metastatic non-small cell lung cancer Multicenter, prospective, open-label, single-arm, phase II trial.

ORGANISM(S): Homo sapiens  

SUBMITTER: Oliver Gautschi   Richard Cathomas  Lukas Bubendorf  Cornelia Dröge  Daniel Rauch  Francesco Zappa  Susanne Crowe  Florent Baty  Martin Früh  Sacha Rothschild  Miklos Pless  Martin Brutsche  Daniel C Betticher 

PROVIDER: E-GEOD-37138 | ArrayExpress | 2013-07-30

SECONDARY ACCESSION(S): GSE37138PRJNA158417

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

| GSE61676 | GEO
2009-09-22 | GSE18195 | GEO
2009-11-16 | E-GEOD-18195 | ArrayExpress
| GSE87455 | GEO
2013-07-01 | E-GEOD-45161 | ArrayExpress
| GSE103668 | GEO
2014-04-25 | E-GEOD-37956 | ArrayExpress
| GSE19862 | GEO
2013-01-03 | E-GEOD-19862 | ArrayExpress
2014-04-25 | E-GEOD-39413 | ArrayExpress